Outcomes of adjuvant platinum-based chemotherapy or radiation therapy in completely resected stage I-IV uterine carcinosarcoma (uCS)

被引:0
|
作者
Makker, V. [1 ]
Abu-Rustum, N. R. [1 ]
Aghajanian, C. A. [1 ]
Hensley, M. L. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
10.1200/jco.2008.26.15_suppl.5560
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5560
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma (UCS) with rhabdomyosarcoma (RMS) differentiation
    Makker, Vicky
    Kravetz, Sara Jane
    Gallagher, Jacqueline
    Orodel, Oana
    Iasonos, Alexia
    DeLair, Deborah
    Zhou, Qin
    Aghajanian, Carol
    Hensley, Martee Leigh
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma
    Makker, Vicky
    Abu-Rustum, Nadeem R.
    Alektiar, Kaled M.
    Aghajanian, Carol. A.
    Zhou, Qin
    Iasonos, Alexia
    Hensley, Martee L.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : 249 - 254
  • [3] Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma
    McEachron, Jennifer
    Heyman, Taryn
    Shanahan, Lisa
    Tran, Van
    Friedman, Monica
    Gorelick, Constantine
    Economos, Katherine
    Singhal, Pankaj K.
    Lee, Yi-Chun
    Kanis, Marguax J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (07) : 1012 - 1017
  • [4] Treatment Outcomes in Completely Resected Stage I to Stage IV Uterine Carcinosarcoma With Rhabdomyosarcoma Differentiation
    Makker, Vicky
    Kravetz, Sara J.
    Gallagher, Jacqueline
    Orodel, Oana-Paula
    Zhou, Qin
    Iasonos, Alexia
    DeLair, Deborah
    Aghajanian, Carol
    Hensley, Martee L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (09) : 1635 - 1641
  • [5] EVALUATION OF THE IMPACT OF POSTOPERATIVE ADJUVANT THERAPY ON SURVIVAL AND RECURRENCE PATTERNS IN STAGE I-IV UTERINE CARCINOSARCOMA
    Mceachron, J.
    Chen, Y-J
    Zhou, N.
    Gorelick, C.
    Kanis, M.
    Fehniger, J.
    Lee, Y. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A123 - A124
  • [6] A clinicopathologic analysis of patients with stage I-IV uterine carcinosarcoma
    Liotta, M.
    Cantrell, L.
    Gehrig, P.
    Alvarez-Secord, A.
    O'Malley, D.
    Havrilesky, L.
    Nutter, B.
    Rose, P.
    Wallace, A.
    Fader, A. Nickles
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S95 - S95
  • [7] The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC)
    Dietrich, CS
    Modesitt, SC
    DePriest, PD
    Ueland, FR
    Wilder, J
    Reedy, MB
    Pavlik, EJ
    Kryscio, R
    Cibull, M
    Giesler, J
    Manahan, K
    Huh, W
    Cohn, D
    Powell, M
    Slomovitz, B
    Higgins, R
    Merritt, W
    Hunter, J
    Puls, L
    Gehrig, P
    van Nagell, JR
    GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : 557 - 563
  • [8] Phase II study of adjuvant gemcitabine plus docetaxel (GD) for completely resected stage I-IV high grade uterine leiomyosarcoma (HGuLMS)
    Hensley, M. L.
    Larkin, J.
    Ishill, N.
    Abu-Rustum, N.
    Sabbatini, P.
    Konner, J.
    Tew, W.
    Spriggs, D.
    Aghajanian, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study
    Hensley, Martee L.
    Ishill, Nicole
    Soslow, Robert
    Larkin, Joseph
    Abu-Rustum, Nadeem
    Sabbatini, Paul
    Konner, Jason
    Tew, William
    Spriggs, David
    Aghajanian, Carol A.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (03) : 563 - 567
  • [10] Impact of EGFR mutation status in patients with completely resected lung adenocarcinoma treated with adjuvant platinum-based chemotherapy
    Yoh, K.
    Goto, K.
    Niho, S.
    Ohmatsu, H.
    Nagai, K.
    Ohe, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)